“An Open-Label, Pilot Study to Evaluate the Benefits of Using Lyophilized Human Milk-Derived Nutritional Product (NeoLact 70 – 1.55 G) As an Immune-Nutritional Supplement in Premature Infants Discharged from NICU”. Indian Journal of Child Health 8, no. 12 (December 28, 2021): 404–407. Accessed November 22, 2024. https://mansapublishers.com/index.php/ijch/article/view/3213.